12:00 AM
 | 
Aug 21, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Alfacell preclinical data

ACEL said that a significant increase (200-400 percent) in tumor apoptosis was seen in leukemia or prostate cell lines treated with Onconase plus all-trans-retinoic acid or phenylbutyrate anticancer...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >